4.4 Article

Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy

期刊

HUMAN PATHOLOGY
卷 45, 期 2, 页码 236-243

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.humpath.2013.08.019

关键词

Proteinuria; IgA nephropathy; Long-term outcome

资金

  1. Yonsei University College of Medicine for [6-2012-0033]
  2. Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A102065]

向作者/读者索取更多资源

Pathologic features can provide valuable information for determining prognosis in IgA nephropathy (IgAN). However, it is uncertain whether the Oxford classification, a new classification of IgAN, can predict renal outcome better than previous ones. We conducted a retrospective cohort study in 500 patients with biopsy-proven IgAN between January 2002 and December 2010 to compare the ability of the Haas and the Oxford classifications to predict renal outcome. Primary outcome was a doubling of the baseline serum creatinine concentration (D-SCr). During a mean follow-up of 68 months, 52(10.4%) and 35 (7.0%) developed D-SCr and end-stage renal disease, respectively. There were graded increases in the development of D-SCr in the higher Haas classes. In addition, the primary endpoint of D-SCr occurred more in patients with the Oxford M and T lesions than those without such lesions. In multivariate Cox regression analyses, the Haas class V (HR, 12.19; P = .002) and the Oxford T1 (hazard ratio [HR], 6.68; P < .001) and T2 (HR, 12.16; P < .001) lesions were independently associated with an increased risk of reaching D-SCr. Harrell's C index of each multivariate model with the Haas and the Oxford classification was 0.867 (P = .015) and 0.881 (P = .004), respectively. This was significantly higher than that of model with clinical factors only (C = 0.819). However, there was no difference in C-statistics between the 2 models with the Haas and the Oxford classifications (P = .348). This study suggests that the Haas and the Oxford classifications are comparable in predicting progression of IgAN. (C) 2014 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据